151 results on '"Mahr S"'
Search Results
2. Minimalinvasiver Aortenklappenersatz über eine anteriore rechtsseitige Thorakotomie
3. The genetics of osteoarthritis in STR/ort mice
4. Association of CMV and Graftvasculopathy: A Changing Paradigm.: Abstract# 1505
5. AN ISOLATED HEART SETUP TO INVESTIGATE DIAGNOSTIC AND CONTROL METHODS FOR ROTARY BLOOD PUMPS: O84 (F.6-5)
6. Institutional Experience with Low Molecular Weight Heparin as an Alternative to Unfractionated Heparin in the Immediate Postoperative Period after Left Ventricular Assist Device Implantation.: Abstract# 1247 Poster Board #-Session: P114-III
7. Cyclosporine vs. Tacrolimus Based Immunosuppression in Patients with a Ventricular Assist Device Undergoing Heart Transplantation.: Abstract# 1210 Poster Board #-Session: P77-III
8. The Eurotransplant (ET) Donor Heart Score: Can It Stand the Test of Real Life?: Abstract# 234
9. Impact of Different ATG Dosing Protocols on Long-Term Outcome after Cardiac Transplantation.: Abstract# 162
10. Do boys and girls match? - Influence of gender mismatch on long term outcome after cardiac transplantartion: 060
11. Graftvaskulopathie des Herzen: Was haben wir nach all den Jahren gelernt?: 058
12. The old for old concept in cardiac transplantation: does it work?: 029
13. Sexual dimorphism in the osteoarthritis of STR/ort mice may be linked to articular cytokines
14. Markscheiderische und bergmännische und Aspekte
15. Renal failure due to toxicants – A proposal for a structured causality assessment
16. PP.39.20
17. Concomitant Surgical Valve Procedures in Patients Undergoing LVAD Implantation
18. Does a Crumbling Bridging Strategy Put Patient at Risk for Cardiac Transplantation?
19. Association of CMV and Graftvasculopathy: A Changing Paradigm.
20. Long-term Outcome of Sirolimus (SRL) Based Immunosuppression (IS) in Heart Transplant Patients
21. Viennese approach to minimize the invasiveness of ventricular assist device implantation
22. 061 * INSTITUTIONAL APPROACH TO MINIMIZE THE INVASIVENESS OF VENTRICULAR ASSIST DEVICE IMPLANTATION
23. 290 * LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION WITH EXTRACORPOREAL MEMBRANE OXYGENATOR SUPPORT IN INTERMACS LEVEL 1 PATIENTS
24. 030 * PREOPERATIVE PATIENT OPTIMIZATION USING EXTRACORPOREAL MEMBRANE OXYGENATION SUPPORT IMPROVES OUTCOMES OF INTERMACS LEVEL 1 PATIENTS RECEIVING A PERMANENT VENTRICULAR ASSIST DEVICE
25. Non-Responders to Antiplatelet Therapy in Patients with Left Ventricular Assist Devices
26. Effect of cerebral protection strategy on outcome of patients with Stanford type A aortic dissection
27. Supra-aortic transposition prior to endovascular stent implantation in the treatment of aortic arch pathologies
28. Tricuspid valve repair for moderate and severe tricuspid valve insufficiency in patients undergoing LVAD implantation
29. Left ventricular assist device implantation with ECMO support instead of cardiopulmonary bypass
30. An isolated large animal heart platform for cardiac research and cardiac device testing
31. Aspirin and clopidogrel non-responder in patients with a left ventricular assist device
32. Minimal invasive LVAD implantation via bilateral thoracotomy
33. 560 Institutional Experience with Low Molecular Weight Heparin as an Alternative to Unfractionated Heparin in the Immediate Postoperative Period after Left Ventricular Assist Device Implantation
34. Institutional experience with extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation
35. Two-dimensional speckle-tracking strain echocardiography in long-term heart transplant patients: a study comparing deformation parameters and ejection fraction derived from echocardiography and multislice computed tomography
36. Post-transplant outcome of elective vs. LVAD vs. urgent patients undergoing cardiac transplantation
37. (628) - Concomitant Surgical Valve Procedures in Patients Undergoing LVAD Implantation
38. (489) - Does a Crumbling Bridging Strategy Put Patient at Risk for Cardiac Transplantation?
39. DO BOYS AND GIRLS MATCH? - INFLUENCE OF GENDER MISMATCH ON LONG TERM OUTCOME AFTER CARDIAC TRANSPLANTARTION
40. 484: New Development of Diabetes in Tacrolimus Treated Patients. Does It Really Matter?
41. CMV infection in the new millenium
42. 572: Post-Transplant Outcome of Elective vs. LVAD vs. Urgent Patients Undergoing Cardiac Transplantation
43. 364: ECMO as Support of Primary Graft Dysfunction (PGD) in Cardiac Transplantation
44. INFLUENCE OF ABO-COMPATIBLE TRANSPLANTATION ON LONG-TERM OUTCOME IN CARDIAC TRANSPLANT RECIPIENTS
45. IMPACT OF ACE-INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER THERAPY ON DEVELOPMENT OF PROTEINURIA AFTER SWITCH TO SIROLIMUS IN CARDIAC TRANSPLANT RECIPIENTS
46. SAFETY AND EFFICACY OF STATIN THERAPY IN PATIENTS SWITCHED FROM CYCLOSPORINE A TO SIROLIMUS AFTER CARDIAC TRANSPLANTATION
47. P247 CIS- AND TRANS-ACTING GENE REGULATION IS ASSOCIATED WITH OSTEOARTHRITIS
48. P240 OVER-EXPRESSION OF RHOB IS ASSOCIATED WITH OSTEOARTHRITIS AND DRIVES APOPTOSIS IN A CHONDROSARCOMA LINE
49. (355) - Long-term Outcome of Sirolimus (SRL) Based Immunosuppression (IS) in Heart Transplant Patients
50. Growth factors control apoptosis of rat gastric enterochromaffin-like cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.